|
Heron Therapeutics, Inc. Closes Underwritten Offering of Common Stock
MarketWatch As a component of the offering, in lieu of common stock, Heron Therapeutics, Inc. also offered and sold to certain existing large investors pre-funded warrants to purchase up to an aggregate of 600,000 shares of common stock at a purchase price of $11 … |
